Skip Navigation



Carcinogenesis Advance Access published online on May 29, 2008

Carcinogenesis, doi:10.1093/carcin/bgm302
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
29/7/1343    most recent
bgm302v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Castro, M. E.
Right arrow Articles by Carnero, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castro, M. E.
Right arrow Articles by Carnero, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function

Maria E. Castro1, Juan F.M. Leal1, Matilde E. Lleonart2, Santiago Ramon y Cajal2 and Amancio Carnero1,3

1 Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
2 Dpto. Anatomía Patológica, Hospital Vall d'Hebrón, Barcelona, Spain

3 Corresponding author: Experimental Therapeutics Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), C/ Melchor Fernández Almagro, 3, 28029, Madrid, Spain, Phone: +34 91 732 8021, Fax: +34 91 224 6976, e-mail: acarnero{at}cnio.es

Introduction of conditional murine p53 (p53val135) and oncogenic ras into double p53/p21-null mouse embryonic fibroblasts showed that p21waf1 was not required for combined ras/p53-induced senescent-like growth arrest. We used this cellular system to identify key players in the ras-p53-induced senescence in the absence of p21. Applying a retroviral-based genetic screen, we obtained mRNA antisense fragments against a cluster of 14 different ribosomal proteins which loss of function bypasses p53-induced growth arrest. The expression of the ribosomal protein antisense fragments reduced the transcriptional activity of p53. Experiments with eGFP-p53 chimeras suggest that the effect is mediated by a reduction of p53. To study whether p53 was downregulated by MDM2-dependent degradation we tested the effect of the RP antisenses in double p53/MDM2 null MEFs and observed that in the absence of MDM2, reduction of the RPs levels also decreases p53 levels. Therefore, although we can not discard other unknown mechanism, we suggest that the decrease in the levels of ribosomal proteins might inhibit p53 specific translation. Finally, quantitative analysis comparing levels of mRNA in tumours vs mRNA in normal tissue of the same organ and patient, showed that a variable percentage of lung, prostate or colon tumours have reduced levels of the RPs tested. Interestingly, in most cases the reduction of ribosomal protein mRNAs occurs only to 50%. Our data suggest that ribosomal proteins imbalance might contribute to p53 regulation through the ribosomal biogenesis checkpoint.

Key Words: p53 • cell cycle • growth arrest • genetic screening • ribosomal proteins

Received October 10, 2007; revised December 12, 2007; accepted December 20, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.